» Articles » PMID: 10972693

Racial Differences in Survival of Patients on Dialysis

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2000 Sep 6
PMID 10972693
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have documented racial differences in the crude mortality rates of patients on dialysis. However, proper interpretation of these findings requires adjustment for potential confounders and comorbid risk factors between the racial groups.

Methods: We examined the clinical data on 3752 Caucasian patients, 451 Southeast Asian patients, 322 South Asian patients, and 319 black patients who were treated with hemodialysis or peritoneal dialysis under a Universal Health Care system in Toronto and prospectively followed between 1981 and 1995. In all patients, a number of comorbid risk factors for survival was assessed at the start of dialysis and was reassessed with their outcome status (that is, continued dialysis, transplantation, death, or loss to follow-up) at least every six months. Cox proportional hazards analysis was used to fit multivariate models predicting patient survival. Pairwise comparisons of the relative hazards of death between the racial groups were performed after stratifying for cardiovascular disease, diabetes mellitus, and hypertension at the start of dialysis, and were adjusted for differences in other comorbid risk factors.

Results: The risk of death in Caucasian patients was significantly increased when compared with Southeast Asian patients, South Asian patients, and black patients [multivariate relative hazards (95% CI): 1.63 (1.36 to 1.97), 1.36 (1.07 to 1.73), 1.34 (1.07 to 1.67), respectively]. Additionally, we detected an interaction between race and cigarette smoking (P < 0. 004), suggesting that in the dialysis patients who smoked, whites had a higher mortality risk compared with non-whites.

Conclusions: Differences in patient survival on dialysis exist between racial groups. However, the genetic and environmental determinants that underlie these differences are presently unknown.

Citing Articles

Kidney Function and Long-Term Risk of End-Stage Kidney Disease and Mortality in a Multiethnic Population.

Ling S, Xu G, Zaccardi F, Khunti K, Brunskill N Kidney Int Rep. 2023; 8(9):1761-1771.

PMID: 37705903 PMC: 10496088. DOI: 10.1016/j.ekir.2023.06.014.


Chronic kidney disease biomarkers and mortality among older adults: A comparison study of survey samples in China and the United States.

Miao H, Liu L, Wang Y, Wang Y, He Q, Jafar T PLoS One. 2022; 17(1):e0260074.

PMID: 35020733 PMC: 8754291. DOI: 10.1371/journal.pone.0260074.


Transmission of SARS-CoV-2 considering shared chairs in outpatient dialysis: a real-world case-control study.

Thadhani R, Willetts J, Wang C, Larkin J, Zhang H, Fuentes L BMC Nephrol. 2021; 22(1):313.

PMID: 34530746 PMC: 8444531. DOI: 10.1186/s12882-021-02518-4.


Transmission of SARS-CoV-2 Considering Shared Chairs in Outpatient Dialysis: A Real-World Case-Control Study.

Thadhani R, Willetts J, Wang C, Larkin J, Zhang H, Fuentes L medRxiv. 2021; .

PMID: 33655270 PMC: 7924295. DOI: 10.1101/2021.02.20.21251855.


Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.

Ng J, Hirsch J, Wanchoo R, Sachdeva M, Sakhiya V, Hong S Kidney Int. 2020; 98(6):1530-1539.

PMID: 32810523 PMC: 7428720. DOI: 10.1016/j.kint.2020.07.030.